| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Troponin I, cardiac muscle|Cardiac troponin I|TNNI3|TNNC1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
rat cTnI/TNNI3 (Cardiac Troponin I) is a molecular target commonly studied in developmental biology, signal transduction, and neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of cTnI/TNNI3 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of cTnI/TNNI3 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
cTnI/TNNI3 (Cardiac Troponin I) may also be referenced as Troponin I, cardiac muscle, Cardiac troponin I, and TNNI3 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how cTnI/TNNI3 relates to neuronal signaling and synaptic function, neuroinflammation, neurodegeneration models, and brain–body communication in developmental biology, signal transduction, and neuroscience research.
- Interpreting shifts in cTnI/TNNI3 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
cTnI/TNNI3 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with developmental biology, signal transduction, and neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Lactylation of HADHA promotes sepsis-induced myocardial depression
IF: 16.2 Journal: Circulation Research Author: Department of Pediatrics, PICU (T.-N.Z., Y.-P.L., R.W., Y.-H.Y., T.Z., C.-F.L., N.Y.), Shengjing Hospital of China Medical University, Shenyang. Cited Date: 2025-09-19
Protective mechanisms of 10-gingerol against myocardial ischemia may involve activation of JAK2/STAT3 pathway and regulation of Ca2+ homeostasis
IF: 6.529 Journal: Biomedicine & Pharmacotherapy Cited Date: 2022-05-19
Surface entrenched β-sitosterol niosomes for enhanced cardioprotective activity against isoproterenol induced cardiotoxicity in rats
IF: 5.8 Journal: International Journal of Pharmaceutics Author: Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, India Cited Date: 2024-02-18
Pachymic Acid Prevents Hemorrhagic Shock-Induced Cardiac Injury by Suppressing M1 Macrophage Polarization and NF-B Signaling Pathway
IF: 5.7 Journal: The American Journal of Chinese Medicine Author: Department of Traditional Chinese Medicine, P. R. China Cited Date: 2023-10-27
WSB1, as an E3 ligase, restrains myocardial ischemia–reperfusion injury by activating β-catenin signaling via promoting GSK3β ubiquitination
IF: 5.7 Journal: Molecular Medicine Author: Department of Function, Sanya Central Hospital (Hainan Third People's Hospital), 1154# Jiefang Fourth Road, Sanya, Hainan Province, China Cited Date: 2024-03-01
Wnt/β-catenin antagonist pyrvinium rescues high dose isoproterenol induced cardiotoxicity in rats: Biochemical and immunohistological evidences
IF: 5.192 Journal: Chemico-Biological Interactions Cited Date: 2022-03-25
Ultrasound-targeted microbubble destruction enhances delayed BMC delivery and attenuates post-infarction cardiac remodelling by inducing engraftment signals
IF: 4.996 Journal: Clinical Science Cited Date: 2016-10-20
PRG4 mitigates hemorrhagic shock-induced cardiac injury by inhibiting mitochondrial dysregulation, oxidative stress and NLRP3-mediated pyroptosis
IF: 4.8 Journal: International Immunopharmacology Author: Department of Critical Care Medicine, Wuxi Ninth People's Hospital Affiliated to Soochow University, Wuxi, Jiangsu 214000, People's Republic of China. Cited Date: 2024-07-05
Schisandrin a Ameliorates Cardiac Injury and Dysfunction Induced by Hemorrhagic Shock via Activating the Nrf2 Signaling Pathway
IF: 4.8 Journal: The American Journal of Chinese Medicine Author: Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.?R.?China. Cited Date: 2024-12-27
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
IF: 4.319 Journal: Drug Design, Development and Therapy Cited Date: 2022-12-08
Melatonin protects against myocardial ischemia-reperfusion injury by inhibiting excessive mitophagy through the Apelin/SIRT3 signaling axis
IF: 4.2 Journal: European Journal of Pharmacology Author: Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.